Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Deferred Taxes (2016 - 2024)

Historic Deferred Taxes for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q4 2024 value amounting to $109000.0.

  • Lifecore Biomedical, Inc. \De\'s Deferred Taxes rose 37250.0% to $109000.0 in Q4 2024 from the same period last year, while for Nov 2024 it was $136000.0, marking a year-over-year decrease of 6650.25%. This contributed to the annual value of $163000.0 for FY2024, which is 5434.17% down from last year.
  • As of Q4 2024, Lifecore Biomedical, Inc. \De\'s Deferred Taxes stood at $109000.0, which was up 37250.0% from -$100000.0 recorded in Q3 2024.
  • Lifecore Biomedical, Inc. \De\'s 5-year Deferred Taxes high stood at $2.4 million for Q2 2020, and its period low was -$5.3 million during Q1 2020.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Deferred Taxes averaged around -$849300.0, with its median value being -$82000.0 (2024).
  • Within the past 5 years, the most significant YoY rise in Lifecore Biomedical, Inc. \De\'s Deferred Taxes was 55972.97% (2020), while the steepest drop was 177420.38% (2020).
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Deferred Taxes stood at -$2.4 million in 2020, then dropped by 17.58% to -$2.8 million in 2021, then skyrocketed by 100.14% to $4000.0 in 2022, then tumbled by 1100.0% to -$40000.0 in 2023, then surged by 372.5% to $109000.0 in 2024.
  • Its last three reported values are $109000.0 in Q4 2024, -$100000.0 for Q3 2024, and -$64000.0 during Q2 2024.